Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Classification criteria for antiphospholipid syndrome.

W A Wilson1

  • 1Department of Medicine, Louisiana State University Medical Center, New Orleans, Louisiana, USA.

Rheumatic Diseases Clinics of North America
|September 6, 2001
PubMed
Summary

The 1999 antiphospholipid syndrome (APS) criteria aid in selecting uniform patient groups for research. Ongoing evaluation and consensus on new APS information will likely refine these criteria for future studies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Remarks on Skin-Grafting, with Cases.

Glasgow medical journal·2018
Same author

Overcoming sequelae of childhood sexual abuse with stress management.

Journal of psychiatric and mental health nursing·2011
Same author

The dental health problem in the United States.

The Journal of the New Jersey State Dental Society·2010
Same author

Problems of Chance in Medicine.

British medical journal·2010
Same author

Hepatic capillariasis in a Cape ground squirrel (Xerus inaurus).

Journal of the South African Veterinary Association·2010
Same author

N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide (ICA-27243): a novel, selective KCNQ2/Q3 potassium channel activator.

Molecular pharmacology·2007

Area of Science:

  • Rheumatology
  • Immunology
  • Clinical Criteria Development

Background:

  • Antiphospholipid syndrome (APS) requires standardized diagnostic criteria for research.
  • Previous criteria facilitated patient selection in lupus and related diseases.

Purpose of the Study:

  • To evaluate the utility of the 1999 international consensus criteria for antiphospholipid syndrome (APS).
  • To assess the criteria's effectiveness in selecting uniform patient cohorts for clinical and experimental studies.

Main Methods:

  • Evaluation of the 1999 international consensus criteria.
  • Testing the criteria in patients with systemic lupus erythematosus or lupus-like diseases.

Main Results:

  • The 1999 criteria appear effective in selecting uniform patient groups for studies, particularly in lupus cohorts.
  • Early evaluations indicate the criteria fulfill their intended purpose.

Conclusions:

  • The 1999 international consensus criteria for APS are valuable for research cohort selection.
  • Future modifications to the APS criteria are anticipated as new information emerges.
  • International symposia play a key role in advancing APS understanding and criteria refinement.

Related Experiment Videos